Across North America, manufacturing facilities, agricultural operations, and commercial workshops face a shared constraint: ...
TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist ...
EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
MusicRadar on MSN
We pit 5 of the best soft synths against each other
We put five of today's most powerful, flexible and versatile synth plugins to the test to find out who comes out on top ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Hosted on MSN
Gemcitabine’s evolving role in cancer care
Gemcitabine remains a mainstay in cancer treatment, but scientists are exploring how it can work alongside cutting-edge therapies. While some drug combinations have failed to improve outcomes, other ...
Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation ...
Polytec's Optical Measurement System. Polytec's optical measurement equipment focuses on dynamic response measurements. MEMS ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
Researchers led by Professor Ting Mei (Northwestern Polytechnical University) and Professors Xiaocong Yuan & Yuquan Zhang ...
Webcast scheduled for Monday, April 27, 2026 at 8:00am ET.BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results